Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
Moehrle
Matthias
M
Breuninger
Helmut
H
Schippert
Wilfried
W
Häfner
Hans-Martin
HM
D000634:Aminoquinolines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D006801:Humans; D000077271:Imiquimod; D015580:Mohs Surgery; D020360:Neoadjuvant Therapy; D009669:Nose Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod